NanOlogy may consider offering expanded access to NanoDoce for patients who do not meet the enrollment criteria of clinical trials in progress.
- Study Type: Expanded Access
- Drug: NanoDoce (sterile nanoparticulate docetaxel) Powder for Suspension
Participating in This Clinical Trial
- Exclusion Criteria:
Gender Eligibility: All
Minimum Age: N/A
Maximum Age: N/A
- Lead Sponsor
- NanOlogy, LLC
- US Biotest, Inc.
- Provider of Information About this Clinical Study
- Overall Contact(s)
- Gere diZerega, MD, 805-595-1300, email@example.com
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.